Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review)
D.M. Simpson, MD, A. Blitzer, MD, DDS, A. Brashear, MD, C. Comella, MD, R Dubinsky, MD, MPH, M. Hallett, MD, J. Jankovic, MD, B. Karp, MD, C.L. Ludlow, PhD, J.M. Miyasaki, MD, Med, M.Naumann, MD, and Y. So, MD, PhD.
American Academy of Neurology, May 6, 2008; 70:1699 - 1706
Article: Botulinum neurotoxin for the treatment of movement disorders
Review with questions: AOCPMR JC December 2011 Review & Questions
Reviewer: Gregory Burkard Jr., OMS-IV, NYCOM, Educational Committee, AOCPMR Student Representative